Previous 10 | Next 10 |
The NASDAQ is finally in formal bear market territory, although, as high growth investors fully know, we have been in a brutal bear market since at least November of 2021. My aggressive growth portfolio has not been spared the extreme pain; however, I am confident in my positions once...
BOULDER, Colo., April 21, 2022 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in AI-data driven proteomics technology, today announced that it will report financial results for the first quarter 2022 after market close on Thursday, May 12, 2022. Company management will host a corresponding c...
BOULDER, Colo., April 12, 2022 (GLOBE NEWSWIRE) -- In one of the largest proteomic studies ever conducted and published April 6 in the journal Science Translational Medicine, scientists at SomaLogic used the SomaScan ® Platform to create and validate a 27-protein clinical test ...
SomaLogic offers a pioneering platform for the study and engineering of various proteins, which lends itself to a large number of diseases giving the company a large pipeline. The company’s business approach sees them partner with other companies, selling the rights to utilize ...
The following slide deck was published by SomaLogic, Inc. in conjunction with their 2021 Q4 earnings call. For further details see: SomaLogic, Inc. 2021 Q4 - Results - Earnings Call Presentation
SomaLogic, Inc. (SLGC) Q4 2021 Earnings Conference Call March 29, 2022, 4:30 PM ET Company Participants Roy Smythe – Chief Executive Officer Melody Harris – President and Chief Operating Officer Shaun Blakeman – Chief Financial Officer Stephen Williams – Chief Medi...
SomaLogic press release (NASDAQ:SLGC): Q4 GAAP EPS of -$0.13 in-line. Revenue of $23M (-18.4% Y/Y) beats by $1.55M. For further details see: SomaLogic GAAP EPS of -$0.13 in-line, revenue of $23M beats by $1.55M
Fourth quarter 2021 revenue of $23.0 million contributed to record full year revenue of $81.6 million, 46% growth over the prior year Established over 75 new customer accounts, expanding and diversifying revenue base Substantial cash and investments of $657.7 million at ...
BOULDER, Colo., March 21, 2022 (GLOBE NEWSWIRE) -- SomaLogic (NASDAQ: SLGC), a leader in data-driven proteomics technology, today announced that the company will begin assaying samples from the European Prospective Investigation into Cancer and Nutrition (EPIC) study beginning in the first ...
BOULDER, Colo., March 01, 2022 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in AI-data driven proteomics technology, today announced that it will report financial results for the fourth quarter and full year 2021 after market close on Tuesday, March 29, 2022. Company management will host a...
News, Short Squeeze, Breakout and More Instantly...
SOUTH SAN FRANCISCO, Calif., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq: LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health , today announced that its stockholders voted to approve all proposals required to be approved in...
SomaLogic Stockholders Vote to Approve Standard BioTools Transaction at Special Meeting PR Newswire Stockholder Approval Represents Key Milestone Toward Completion of Standard BioTools Transaction Combination Will Create a Diversified Leader in Life Sciences Tools ...
Believes All SomaLogic Directors – Robert Barchi , Thomas Carey , Eli Casdin , Troy Cox , Kathy Hibbs , Anne Margulies , Tycho Peterson , Richard Post and Jason Ryan – Have Betrayed Shareholders by Delaying the Special Meeting Five Times so the Bo...